Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Systemic Lupus Erythematosus
100%
Rheumatoid Arthritis
86%
Methotrexate
70%
Elderly Patients
45%
Anti-DNA Antibodies
45%
Interleukin-1β
39%
Idiotype
33%
Nasogastric Tube
33%
Methotrexate Treatment
32%
Aged Mice
30%
Cytokine Production
27%
Tube Feeding
25%
Systemic Lupus Erythematosus Patient
23%
Immunization
21%
Autoantibodies
19%
Osteoarthritis
17%
T Cells
17%
Monoclonal Antibody
16%
Interleukin-4 (IL-4)
16%
Pharmacokinetics
16%
Rheumatoid Arthritis Patients
16%
Interleukin-10
16%
Frail Elderly
16%
Geriatric Patients
15%
Increased Incidence
15%
Israeli Jews
15%
Oral Administration
15%
Peptide-based
15%
First-degree Relatives
15%
T Cell Activation
15%
Aging Effect
15%
Jewish Population
15%
Immune Response
15%
Aging
14%
Mechanism of Action
13%
Erythrocyte Sedimentation Rate
13%
Complementarity-determining Region 3 (CDR3)
13%
Interleukin-2
13%
Long-term Care
12%
Clinical Manifestations
12%
Proliferative Response
11%
Low-dose Methotrexate
11%
Th2 Cytokines
11%
Israeli
10%
Cytokine Profile
10%
Th1 Cytokines
10%
DRB1
10%
Autoantibody Production
10%
Inflammatory Cytokines
10%
Tumor Necrosis Factor-α
10%
Immunology and Microbiology
Systemic Lupus Erythematosus
71%
Inflammatory Arthritis
67%
Experimental Systemic Lupus Erythematosus
62%
Methotrexate
61%
Cytokine
49%
Autoantibodies
30%
Idiotype
28%
Cytokine Production
25%
Peptides
23%
T Cell
20%
Tumor Necrosis Factor
17%
Monoclonal Antibody
16%
Immune Response
15%
Sjögren's Syndrome
15%
Interleukin 10
13%
T Helper Cell
12%
Interleukin-1
11%
Low Drug Dose
11%
Antigen Specificity
11%
Interleukin 4
11%
DNA Antibody
11%
Erythrocyte Sedimentation Rate
11%
Complementarity Determining Region
10%
Interleukin 2
10%
Regulatory T Cell
8%
Murine
8%
Antiidiotypic Antibody
8%
Peripheral Blood Lymphocyte
8%
Immune Complex
8%
Secretion (Process)
7%
Blood Level
7%
Haplotype
7%
Antiphospholipid Antibody
7%
Rheumatic Disease
7%
CD4 CD8 Ratio
7%
Urinary Tract
7%
Vagina
7%
T Helper 2 Cell
7%
Immunosurveillance
7%
Cell Activity
7%
Immunogenetics
7%
Aspartate Aminotransferase Blood Level
7%
Temporomandibular Joint
7%
Prostate
7%
Severe Combined Immunodeficiency
7%
T Helper 1 Cell
7%
Acute Phase Response
7%
Cell Function
7%
HLA-B27
7%
Computer Assisted Tomography
7%